Categories
Pediatric Cancer

Box Car Movie Night | Fight Childhood Cancer Month [Video]

The New Revolution Foundation teamed up with local non-profit Binkeez for Comfort to host local childhood cancer patients are their families. They designed their very own box cars with the help of Andrew Farrell, Brad knighting and Brandon bye, Binkeez blanket to watch a film.———————————————————————————More videos at http://www.revolutionsoccer.net/videosGet Tickets: http://www.revolutionsoccer.net/ticketsView Revolution Roster: http://www.revolutionsoccer.net/club/playersFull Revolution Schedule: http://www.revolutionsoccer.net/schedule

Categories
Pediatric Cancer

Elsie Mae’s Story – Childhood Cancer Awareness Month [Video]

“It was like somebody put a little blanket around us and told us, you know, it’s okay. You know, here, you’re safe. Here you can breathe.”Elsie Mae was just two years old when she was diagnosed with Leukaemia. This diagnosis shattered her parent’s world.Elsie Mae’s treatment was so tough on her that she developed a fear of the hospital, a fear of nurses. Anyone even wearing blue approaching her would make her afraid. Before her diagnosis, Elsie Mae enjoyed going around the farm with her dad David, checking on all the animals. All of a sudden, when Elsie Mae became sick, the world had closed in on her, and it became just one small room.When the Scally family came to Barretstown, it gave them a chance to see that there is something outside of treatment – that there is life outside cancer. It built up their children’s confidence, and they got a glimpse of their little girl back. This #ChildhoodCancerAwarenessMonth, we are sharing the stories of campers who have experienced the terrible hardship that cancer causes, and how our therapeutic programmes help families to rediscover the joys that childhood holds.https://www.barretstown.org/events/barretstown-med-shed-appeal/

Categories
Pediatric Cancer

Global Policy Series: The Impact of Policy and Regulation on Global Inequities in Pediatric Cancer [Video]

2022 Global Policy Webinar Series: The Impact of Policy and Regulation on Global Inequities in Pediatric CancerSERIES OVERVIEW:This two-part webinar series, Understanding the Global Challenges to Equitable, High-Quality Cancer Care, will provide an opportunity for a varied group of global stakeholders including patients, patient advocates, oncology providers, policymakers, and caregivers, to highlight and discuss global challenges to equitable and high-quality cancer care, across the continuum of care, from diverse geographic perspectives. The sessions also will provide a platform for patients worldwide to discuss inequities in treatment options and care in their country and within their respective health systems.This live webinar occurred 20 September 2022. Agenda: 00:00 – Welcome Robert W. Carlson, MD Chief Executive Officer, NCCN05:07 – Unseen and Unheard: The Need to Increase Access to Pediatric Clinical Trials in Sub-Saharan Africa Emmanuella Amoako, MDDirector of Clinical Affairs, Yemaachi BiotechPediatric Oncology Fellow, Korle Bu Teaching Hospital 32:55 – Panel Discussion: The Impact of Policy and Regulation on Global Inequities in Pediatric CancerModerated by Wui-Jin Koh, MDSenior Vice President/Chief Medical Officer, NCCNPanelists:Emmanuella Amoako, MDDirector of Clinical Affairs, Yemaachi Biotech Jamie E. Flerlage, MD, MSAssistant Member, St. Jude Faculty Alejandra MendezVice President, Fundación Nuestros Hijos in Chile Bindu N. NairFounder & Managing Trustee, Aroh-Giving Hope 1:52:45 – ClosingKaty Winckworth-PrejsnarManager, Global Policy & Strategic Alliance, NCCN______________________________________________________________About NCCN: The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?sub_confirmation=1 Connect with us! Twitter: https://twitter.com/NCCN LinkedIn: https://www.linkedin.com/company/nccnFacebook: https://www.facebook.com/NCCNorg Instagram: https://www.instagram.com/NCCNorg

Categories
Pediatric Cancer

Scientist Stories: Crystal Mackall, Pioneer in Immune Cell Exhaustion and Cell Therapies [Video]

Crystal L Mackall MD is the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University, the Founding Director of the Stanford Center for Cancer Cell Therapy, Associate Director of the Stanford Cancer Institute, Leader of the Cancer Immunotherapy Program and Director of the Parker Institute for Cancer Immunotherapy @ Stanford. During a 27-year tenure at NCI culminating as Chief of the Pediatric Oncology Branch and Head of the Immunology Section and since 2016 at Stanford, she has led an internationally recognized translational research program focused on immune-oncology. Her work has advanced understanding of fundamental immunology and translated this understanding for the treatment of human disease with a major focus on children’s cancers. She has led numerous first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines, and adoptive immunotherapy using NK cells and genetically modified T cells. Her work is credited with identifying an essential role for the thymus in human T cell regeneration (NEJM 1995) and discovering IL-7 as the master regulator of T cell homeostasis (Blood 2001, J Exp Med 2008). Her group was among the first to demonstrate impressive activity of CD19-CAR in pediatric leukemia (Lancet 2015), developed a CD22-CAR that is the only active salvage therapy for CAR19 resistant B cell malignancies (Nat Med 2018, J Clin Onc 2020, Blood 2021), demonstrated preclinical activity of GD2 targeting CARs for pediatric diffuse intrinsic pontine glioma (Nat Med 2018), demonstrated superiority of regional CNS delivery of CAR T cells for brain tumors (Nat Med 2020) and demonstrated impressive clinical activity of GD2-CAR T cells in this disease (NCT04196413), which is among the first to demonstrate significant and consistent activity of CAR T cells in solid cancers (Nature 2022). Her group identified T cell exhaustion as a major feature CAR T cell potency (Nat Med 2015), created the first exhaustion-resistance (Nature 2019) and exhaustion-reversal platforms (Science 2021) and developed a best-in-class regulatable “remote-controlled” CAR T cell platform (Cell, 2022). She serves in numerous national leadership positions, including Co-PI of a Pediatric Immunotherapy Discovery and Development Network U54 grant, and co-Leader of the St. Baldrick’s-StandUp2Cancer Pediatric Dream Team. She has received numerous awards, including election as a fellow of the AACR Academy, the Smalley Award for outstanding contributions to cancer immunotherapy from the Society for the Immunotherapy of Cancer, the AACR-St.Baldrick’s Distinguished Achievement Award for Pediatric Cancer Research, and the Nobility in Science Award from the Sarcoma Foundation of America. She has published over 250 manuscripts and her h-index in August 2022 according to google scholar is 96 and founded 3 biotech companies. Crystal is Board Certified in Pediatrics, Pediatric Hematology-Oncology and Internal Medicine.https://en.wikipedia.org/wiki/Crystal_Mackall#biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews Axial Newsletter: https://axial.substack.com/Build with Axial: https://axial22.axialvc.com/

Categories
Pediatric Cancer

AFT 2022 Workshop – Cancer Research: Opportunities for Armenia – Part 2. [Video]

https://armeniansforward.org/forum2022/cancer-researchOrganizers:Gevorg Tamamyan, ArmeniaHead of the Pediatric Cancer and Blood Disorders Center of Armenia at the Hematology Center named after prof. R. Yeolyan,Chairman and Professor, Department of Pediatric Oncology and Hematology of Yerevan State Medical UniversityCEO, Immune Oncology Research InstituteKaren Bedirian, ArmeniaProjects Director, Immune Oncology Research InstituteResearcher, Hematology Center named after prof. R. Yeolyan

Categories
Pediatric Cancer

Together accelerating the cure of cancer in children and adolescents 2022 [Video]

Recording of the webinar ” Together accelerating the cure of cancer in children and adolescents 2022″ held on September 21st, 2022, as part of the activities of the campaign, “September, childhood cancer awareness month”. The session addressed the topic of universal coverage in the care of children and adolescents with cancer; it constitutes the second pillar of the “CureAll” technical package. “CureAll” aims to increase the survival rate of childhood and adolescent cancer to at least 60% by the year 2030, and improve the quality of life of pediatric cancer patients.